Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Seraphim Space (SSIT) Share Price

Price 187.60p on 30-06-2026 at 14:54:38
Change 5.60p 3.08%
Buy 188.00p
Sell 187.00p
Last Trade: Sell 80.00 at 187.45p
Day's Volume: 987,462
Last Close: 182.00p
Open: 184.00p
ISIN: GB00BKPG0138
Day's Range 183.00p - 189.80p
52wk Range: 66.20p - 280.00p
Market Capitalisation: £444.98m
VWAP: 186.56167p
Shares in Issue: 237.20m

Seraphim Space (SSIT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 80 187.45p Ordinary
15:54:38 - 30-Jun-26
Buy* 635 188.00p SI Trade
15:54:38 - 30-Jun-26
Sell* 526 187.45p Ordinary
15:54:36 - 30-Jun-26
Unknown* 6 188.00p OTC Trade
15:53:33 - 30-Jun-26
Unknown* 6 188.00p OTC Trade
15:53:33 - 30-Jun-26
Buy* 525 187.84p Ordinary
15:53:15 - 30-Jun-26
Buy* 260 188.1757p Ordinary
15:46:43 - 30-Jun-26
Buy* 526 188.1757p Ordinary
15:46:30 - 30-Jun-26
Buy* 2,000 188.1757p Ordinary
15:44:26 - 30-Jun-26
Sell* 2,182 187.60p Automatic Execution
15:42:30 - 30-Jun-26
See more Seraphim Space trades

Seraphim Space (SSIT) Share Price History

Time period:
to
Date Open High Low Close Volume
29th Jun 2026 (Mon) 181.00 183.60 175.60 182.00 1,800,316
26th Jun 2026 (Fri) 183.40 183.40 175.20 180.00 3,131,176
25th Jun 2026 (Thu) 180.00 191.00 180.00 184.40 1,792,933
24th Jun 2026 (Wed) 186.00 186.60 177.20 181.20 1,717,228
23rd Jun 2026 (Tue) 193.60 193.60 178.00 185.60 3,375,647
22nd Jun 2026 (Mon) 201.00 201.00 192.00 193.00 1,543,397
19th Jun 2026 (Fri) 199.80 201.00 192.80 201.00 5,224,660
18th Jun 2026 (Thu) 201.00 205.00 198.00 199.20 1,766,456
17th Jun 2026 (Wed) 193.20 203.50 193.00 203.50 1,808,870
16th Jun 2026 (Tue) 195.40 198.00 189.00 195.20 3,031,519
15th Jun 2026 (Mon) 203.00 204.00 190.00 196.20 3,777,167
12th Jun 2026 (Fri) 211.00 223.50 201.50 204.00 3,804,297
11th Jun 2026 (Thu) 195.60 210.00 194.00 207.00 2,349,123
10th Jun 2026 (Wed) 203.00 203.00 190.80 194.60 3,627,399
9th Jun 2026 (Tue) 231.00 235.00 200.00 202.50 15,371,080
8th Jun 2026 (Mon) 178.00 190.00 170.60 187.00 4,890,175
5th Jun 2026 (Fri) 191.20 191.20 174.00 176.80 5,641,158
4th Jun 2026 (Thu) 187.40 193.00 178.80 187.00 6,094,610
3rd Jun 2026 (Wed) 210.00 210.00 185.40 187.40 10,493,346
2nd Jun 2026 (Tue) 235.50 235.50 206.50 209.50 5,066,432
1st Jun 2026 (Mon) 248.50 248.50 226.00 231.50 4,330,109
See more Seraphim Space price history

Seraphim Space (SSIT) Regulatory News

Date Source Headline
26th Jun 2026 1:00 pm RNS Director/PDMR Shareholding
17th Jun 2026 2:39 pm RNS Holding(s) in Company
10th Jun 2026 1:03 pm RNS Holding(s) in Company
9th Jun 2026 8:27 am RNS Holding(s) in Company
9th Jun 2026 7:19 am RNS ICEYE Financing Round
8th Jun 2026 7:00 am RNS Admission to the FTSE 250 Index
5th Jun 2026 10:12 am RNS Director/PDMR Shareholding
5th Jun 2026 10:08 am RNS Director/PDMR Shareholding
5th Jun 2026 7:00 am RNS-R SpaceTech Sector Newsletter - May 2026
3rd Jun 2026 7:00 am RNS 3rd Quarter Results
See more Seraphim Space regulatory news

Seraphim Space (SSIT) Share News

WINNERS & LOSERS: Moonpig flying high as results beat consensus

25th Jun 2026 10:06

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday. Read More

WINNERS & LOSERS: Telecom Plus cuts dividend, warns on profit

23rd Jun 2026 09:58

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

WINNERS & LOSERS: Seraphim Space surges; Silver Bullet plans to delist

9th Jun 2026 11:06

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

WINNERS & LOSERS: GSK falls after Nuvalent buy; Molten Ventures jumps

9th Jun 2026 10:34

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

9th Jun 2026 07:58

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More

See more Seraphim Space news
FTSE 100 Latest
Value10,505.22
Change21.00

Login to your account

Forgot Password?

Not Registered